Literature DB >> 29115096

Letter to the Editor: Effects of Omega-3 Fatty Acids on Erectile Dysfunction in a Rat Model of Atherosclerosis-induced Chronic Pelvic Ischemia.

Emin Özbek1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29115096      PMCID: PMC5680513          DOI: 10.3346/jkms.2017.32.12.2085

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


× No keyword cloud information.
Dear Editor, I have read the article “Effects of Omega-3 Fatty Acids on Erectile Dysfunction in a Rat Model of Atherosclerosis-induced Chronic Pelvic Ischemia” written by Shim et al. (1), which was an interesting study investigating the protective effect of of omega-3 fatty acids on erectile dysfunction in a rat model of atherosclerosis-induced chronic pelvic ıschemia. In this study, they showed that omega-3 fatty acids improved intracavernosal pressure and had a beneficial role against pathophysiological consequences such as fibrosis or hypoxic damage on chronic pelvic ischemia rat model, which represents a structural erectile dysfunction model. Yet, this article is open to critism from several aspects. Ischemic and hypercholesterolemic conditions resulted in erectile dysfunction as stated in this experiment. In ischaemic conditions reactive oxygene species, nuclear factor kappa b and inducible nitric oxide synthase pathway is involved (23). It would be better if this pathway had been studied. Transforming growth factor β (TGF-β) expression in cavernosal tissues had been evaluated, but TGF-β indirectly informed about collagen expression and fibrosis. Together with TGF-β1, it would be better if collagen, especially type-1, and fibrosis were observed (4). Most of the tissue responses during ischaemic conditions occur through the induction of the transcription factor hypoxia-inducible factor-1 (HIF-1) which regulates many processes needed for tissue repair during ischemia in the damaged tissue. Vascular endothelial growth factor (VEGF) is one of the transcriptionally regulated soluble growth factor by HIF-1 (5). It would be better if the effect of omega-3 fatty acids on VEGF expression were studied in penile tissues. By using corpus cavernosum tissues to evaluate the contractile responses to phenylephrine and relaxation responses to carbachol is a good method in organ bath, which enables to investigate isometric tension changes in response to various bioactive agents and electrical field stimulation in in vitro models. This method gives us functional information about penile function and nitric oxide (NO)/cyclic guanosine monophosphate pathway (56). Intracavernosal presssure measurement following cavernosal nerve stimulation without study of organ bath is another flaw of this experiment. It is well known that omega-3 fatty acids are strong antioxidant and used as a ROS scavenging agents in literature (7). In the current study, antioxidant efficacy of omega-3 fatty acids had not been evaluated. It reported that atherosclerosis-associated endothelial dysfunction reduced nitric oxide bioavailability and caused nitric oxide synthase (NOS)-uncoupling (89). These are main results of increased ROS and caused erectile dysfunction. Certain antioxidants prevent NOS-uncoupling and reverse nitric oxide bioavailability (10). It would be better when the preventive effect of omega-3 fatty acids was studied against reduced NO bioavailability and NOS-uncoupling. Finally, preventive effects of omega-3 fatty acids in the ischemic penile tissues could be evaluated in line with my recommendations and used as a supplementary agent in aged patients with suspected pelvic ischemia.
  10 in total

1.  Atherosclerosis-associated endothelial dysfunction.

Authors:  V Schächinger; A M Zeiher
Journal:  Z Kardiol       Date:  2000

2.  The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus.

Authors:  Orhan Bas; Ahmet Songur; Onder Sahin; Hakan Mollaoglu; Oguz Aslan Ozen; Mehmet Yaman; Olcay Eser; Huseyin Fidan; Murat Yagmurca
Journal:  Neurochem Int       Date:  2006-12-21       Impact factor: 3.921

3.  The effect of long-term oral tadalafil treatment on corpus cavernosum function in an experimental spinal cord transection rat model.

Authors:  S Toksoz; S R Erdem; C L Peskircioglu; U Keskin
Journal:  Spinal Cord       Date:  2013-09       Impact factor: 2.772

Review 4.  Hypoxia and hypoxia signaling in tissue repair and fibrosis.

Authors:  Zerina Lokmic; James Musyoka; Timothy D Hewitson; Ian A Darby
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 5.  Caveolin1/protein arginine methyltransferase1/sirtuin1 axis as a potential target against endothelial dysfunction.

Authors:  Soniya Charles; Vijay Raj; Jesu Arokiaraj; Kanchana Mala
Journal:  Pharmacol Res       Date:  2017-01-23       Impact factor: 7.658

Review 6.  Myocardial ischaemia reperfusion injury: the challenge of translating ischaemic and anaesthetic protection from animal models to humans.

Authors:  Z Xia; H Li; M G Irwin
Journal:  Br J Anaesth       Date:  2016-09       Impact factor: 9.166

7.  Quercetin treatment against ischemia/reperfusion injury in rat corpus cavernosum tissue: a role on apoptosis and oxidative stress.

Authors:  Ö Çevik; S Çadırcı; T E Şener; I Tinay; C Akbal; H H Tavukçu; S Çetinel; D Kıran; G Şener
Journal:  Free Radic Res       Date:  2013-07-08

8.  Effects of Omega-3 Fatty Acids on Erectile Dysfunction in a Rat Model of Atherosclerosis-induced Chronic Pelvic Ischemia.

Authors:  Ji Sung Shim; Dae Hee Kim; Jae Hyun Bae; Du Geon Moon
Journal:  J Korean Med Sci       Date:  2016-02-22       Impact factor: 2.153

Review 9.  Modulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the Heart.

Authors:  Csaba Csonka; Márta Sárközy; Márton Pipicz; László Dux; Tamás Csont
Journal:  Oxid Med Cell Longev       Date:  2015-12-14       Impact factor: 6.543

Review 10.  Resveratrol and endothelial nitric oxide.

Authors:  Ning Xia; Ulrich Förstermann; Huige Li
Journal:  Molecules       Date:  2014-10-09       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.